Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
5 weeks 14 hours ago
9 weeks 1 day ago
10 weeks 1 day ago
10 weeks 1 day ago
31 weeks 2 days ago
35 weeks 3 days ago
37 weeks 5 hours ago
37 weeks 1 day ago
49 weeks 3 days ago
1 year 3 weeks ago